OMER

EPS: -0.59 Rev: 10M Net Inc: 56M

Income Statement

Expenses

Assets

Assets (Current)

Assets (Non-Current)

Liabilities

Liabilities (Current)

Liabilities (Non-Current)

Cash Flow

Cash Flow Financing

OMER vs Biotechnology (76 peers) - Healthcare

Gross Margin

98.9%

+22.2pp vs peers

Operating Margin

-117.9%

-148.6pp vs peers

Net Margin

-136.6%

-162.2pp vs peers

ROIC

-186.5%

-284.0pp vs peers

Related: REGN INCY VRTX NTLA SVRA ARDX ALLO IOVA CHRS CPRX